Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa

Science. 2010 Feb 19;327(5968):1010-3. doi: 10.1126/science.1182749.

Abstract

Antibiotics with new mechanisms of action are urgently required to combat the growing health threat posed by resistant pathogenic microorganisms. We synthesized a family of peptidomimetic antibiotics based on the antimicrobial peptide protegrin I. Several rounds of optimization gave a lead compound that was active in the nanomolar range against Gram-negative Pseudomonas spp., but was largely inactive against other Gram-negative and Gram-positive bacteria. Biochemical and genetic studies showed that the peptidomimetics had a non-membrane-lytic mechanism of action and identified a homolog of the beta-barrel protein LptD (Imp/OstA), which functions in outer-membrane biogenesis, as a cellular target. The peptidomimetic showed potent antimicrobial activity in a mouse septicemia infection model. Drug-resistant strains of Pseudomonas are a serious health problem, so this family of antibiotics may have important therapeutic applications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Antimicrobial Cationic Peptides / chemistry
  • Bacterial Outer Membrane Proteins / chemistry
  • Bacterial Outer Membrane Proteins / genetics
  • Bacterial Outer Membrane Proteins / metabolism*
  • Cell Membrane / metabolism*
  • Drug Design
  • Drug Resistance, Bacterial / genetics
  • Genes, Bacterial
  • Lipopolysaccharides / metabolism
  • Mice
  • Microbial Sensitivity Tests
  • Molecular Mimicry
  • Mutation
  • Peptide Library
  • Peptides / chemical synthesis
  • Peptides / chemistry
  • Peptides / metabolism
  • Peptides / pharmacology*
  • Protein Structure, Tertiary
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / growth & development
  • Pseudomonas aeruginosa / metabolism*
  • Pseudomonas aeruginosa / ultrastructure
  • Sepsis / drug therapy
  • Sepsis / microbiology

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Bacterial Outer Membrane Proteins
  • Lipopolysaccharides
  • Peptide Library
  • Peptides
  • protegrin-1